The First Affiliated Hospital Of Zhengzhou University
Clinical trials sponsored by The First Affiliated Hospital Of Zhengzhou University, explained in plain language.
-
Heart artery breakthrough: balloon treatment challenges traditional stents
Disease control Recruiting nowThis study compares two treatments for completely blocked heart arteries: drug-coated balloons versus traditional stents. Researchers want to see if balloons (which leave no metal behind) work as well as stents at keeping arteries open long-term. The trial involves 200 patients w…
Phase: NA • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test new pill to boost stomach cancer treatment
Disease control Recruiting nowThis study is testing whether adding a new oral medication (SHR2554) to a standard immunotherapy-plus-chemotherapy combo works better for advanced stomach cancer. It will enroll 36 adults who have not yet received treatment for their advanced disease. The goal is to see if this t…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Massive 15,000-Person hunt for best hepatitis b treatment to stop liver cancer
Disease control Recruiting nowThis large study is observing 15,000 adults with chronic hepatitis B across 200 hospitals in China. It aims to see which standard antiviral treatments work best in the real world to lower the risk of developing liver cancer and improve other health outcomes. The goal is to gather…
Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC